But instead Patanjali's sales plunged 10% to ₹8,100 crore, according to its annual financial report. The 46-year-old Balkrishna, whose net worth Forbes puts at $4.9 billion, brushed aside concerns about the company's health during an April interview at one of Patanjali's yoga centres near Haridwar. Santosh K.C., an official at Nepal's Department of Drug Administration, said there were no problems with other Patanjali products. Patanjali products marketed as ayurvedic come under the regulatory purview of the Ministry of Ayush, created in 2014 to promote alternative therapies including Ayurveda. Reuters reviewed 81 Patanjali products in a Mumbai Patanjali store and found that 27 of them had labels that listed the goods as partially or wholly manufactured by other Indian producers.

Source: Mint June 12, 2019 04:52 UTC